Meningococcal Meningitis Surveillance in the African Meningitis Belt, 2004-2013
- PMID: 26553668
- PMCID: PMC4639499
- DOI: 10.1093/cid/civ597
Meningococcal Meningitis Surveillance in the African Meningitis Belt, 2004-2013
Abstract
Background: An enhanced meningitis surveillance network was established across the meningitis belt of sub-Saharan Africa in 2003 to rapidly collect, disseminate, and use district weekly data on meningitis incidence. Following 10 years' experience with enhanced surveillance that included the introduction of a group A meningococcal conjugate vaccine, PsA-TT (MenAfriVac), in 2010, we analyzed the data on meningitis incidence and case fatality from countries reporting to the network.
Methods: After de-duplication and reconciliation, data were extracted from the surveillance bulletins and the central database held by the World Health Organization Inter-country Support Team in Burkina Faso for countries reporting consistently from 2004 through 2013 (Benin, Burkina Faso, Chad, Democratic Republic of Congo, Ghana, Côte d'Ivoire, Mali, Niger, Nigeria, Togo).
Results: The 10 study countries reported 341 562 suspected and confirmed cases over the 10-year study period, with a marked peak in 2009 due to a large epidemic of group A Neisseria meningitidis (NmA) meningitis. Case fatality was lowest (5.9%) during this year. A mean of 71 and 67 districts annually crossed the alert and epidemic thresholds, respectively. The incidence rate of NmA meningitis fell >10-fold, from 0.27 per 100,000 in 2004-2010 to 0.02 per 100,000 in 2011-2013 (P < .0001).
Conclusions: In addition to supporting timely outbreak response, the enhanced meningitis surveillance system provides a global overview of the epidemiology of meningitis in the region, despite limitations in data quality and completeness. This study confirms a dramatic fall in NmA incidence after the introduction of PsA-TT.
Keywords: Africa; meningitis; surveillance.
© 2015 World Health Organization; licensee Oxford Journals.
Figures



Similar articles
-
Impact of MenAfriVac in nine countries of the African meningitis belt, 2010-15: an analysis of surveillance data.Lancet Infect Dis. 2017 Aug;17(8):867-872. doi: 10.1016/S1473-3099(17)30301-8. Epub 2017 May 22. Lancet Infect Dis. 2017. PMID: 28545721
-
The burden of meningococcal meningitis in the African Meningitis Belt, from 2009 to 2014: a trend analysis.Pan Afr Med J. 2021 May 20;39:57. doi: 10.11604/pamj.2021.39.57.17629. eCollection 2021. Pan Afr Med J. 2021. PMID: 34422180 Free PMC article.
-
Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data.Lancet Infect Dis. 2012 Oct;12(10):757-64. doi: 10.1016/S1473-3099(12)70168-8. Epub 2012 Jul 18. Lancet Infect Dis. 2012. PMID: 22818241 Free PMC article.
-
Emergence of serogroup X meningococcal disease in Africa: need for a vaccine.Vaccine. 2013 Jun 12;31(27):2852-61. doi: 10.1016/j.vaccine.2013.04.036. Epub 2013 Apr 24. Vaccine. 2013. PMID: 23623866 Review.
-
Narrative review of methods and findings of recent studies on the carriage of meningococci and other Neisseria species in the African Meningitis Belt.Trop Med Int Health. 2019 Feb;24(2):143-154. doi: 10.1111/tmi.13185. Epub 2018 Dec 6. Trop Med Int Health. 2019. PMID: 30461138 Free PMC article. Review.
Cited by
-
Hospital-based Surveillance Provides Insights Into the Etiology of Pediatric Bacterial Meningitis in Yaoundé, Cameroon, in the Post-Vaccine Era.Clin Infect Dis. 2019 Sep 5;69(Suppl 2):S148-S155. doi: 10.1093/cid/ciz506. Clin Infect Dis. 2019. PMID: 31505633 Free PMC article.
-
Implementation of Case-Based Surveillance and Real-time Polymerase Chain Reaction to Monitor Bacterial Meningitis Pathogens in Chad.J Infect Dis. 2019 Oct 31;220(220 Suppl 4):S182-S189. doi: 10.1093/infdis/jiz366. J Infect Dis. 2019. PMID: 31671450 Free PMC article.
-
Assessing the Importance of Domestic Vaccine Manufacturing Centers: An Overview of Immunization Programs, Vaccine Manufacture, and Distribution.Front Immunol. 2018 Jan 18;9:26. doi: 10.3389/fimmu.2018.00026. eCollection 2018. Front Immunol. 2018. PMID: 29403503 Free PMC article. Review.
-
Cost-effectiveness of expanding childhood routine immunization against Neisseria meningitidis serogroups C, W and Y with a quadrivalent conjugate vaccine in the African meningitis belt.PLoS One. 2017 Nov 30;12(11):e0188595. doi: 10.1371/journal.pone.0188595. eCollection 2017. PLoS One. 2017. PMID: 29190699 Free PMC article.
-
Evaluation of the Impact of Meningococcal Serogroup A Conjugate Vaccine Introduction on Second-Year-of-Life Vaccination Coverage in Burkina Faso.J Infect Dis. 2019 Oct 31;220(220 Suppl 4):S233-S243. doi: 10.1093/infdis/jiz304. J Infect Dis. 2019. PMID: 31671442 Free PMC article.
References
-
- Greenwood B. Manson lecture. Meningococcal meningitis in Africa . Trans R Soc Trop Med Hyg 1999; 93:341–53. - PubMed
-
- The Meningitis Vaccine Project. Available at: http://meningvax.org/mission.php Accessed 23 April 2015.
-
- World Health Organization. Standard operating procedures for enhanced meningitis surveillance in Africa. Ouagadougou, Burkina Faso: WHO Regional Office for Africa, 2009. Available at: http://www.meningvax.org/files/WHO_SOP_EN_2009.pdf Accessed 18 October 2014.
-
- R Foundation for Statistical Computing. Available at: http://www.R-project.org Accessed 16 March 2015.
-
- World Health Organization, Inter-country Support Team. Epidemiological information. Available at: http://www.who.int/csr/disease/meningococcal/epidemiological/en/ Accessed 16 March 2015.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous